2014
DOI: 10.1016/j.ejogrb.2014.06.008
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED: Adding l-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
53
2
4

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 53 publications
(64 citation statements)
references
References 21 publications
5
53
2
4
Order By: Relevance
“…This was in agreement with the study of Ismail et al, as they reported that there was a highly statistical significant difference (P<0.0001) between the two groups, in which the L-carnitine group had a mean number of follicles more than the placebo group [10] . This was also in agreement with the study of Latifian et al, as they reported that there was a statistical significant difference (P<0.05) in the favour of the women that received L-carnitine [6] .…”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…This was in agreement with the study of Ismail et al, as they reported that there was a highly statistical significant difference (P<0.0001) between the two groups, in which the L-carnitine group had a mean number of follicles more than the placebo group [10] . This was also in agreement with the study of Latifian et al, as they reported that there was a statistical significant difference (P<0.05) in the favour of the women that received L-carnitine [6] .…”
Section: Discussionsupporting
confidence: 93%
“…This was in agreement with the study of Ismail et al, as they reported that there was a highly statistical significant difference (P<0.0001) between the two groups, in which the placebo group needed more days than the L-carnitine group to reach the desired follicle size [10] .…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…There were 33 RCTs comprising a total of 4349 women with WHO group II anovulation, undergoing 7210 treatment cycles. Of the 33 included studies, participants were women with PCOS (without CC resistance) in 25 studies, women with CC‐resistant PCOS in five studies, women with WHO group II anovulation (with or without PCOS) in two studies and women with WHO group II anovulation (without PCOS) in one study. The characteristics of these 33 included studies are listed in Table .…”
Section: Resultsmentioning
confidence: 99%